[Clinical and immunological improvement of myasthenia gravis following treatment with denosumab]. [electronic resource]
Producer: 20180309Description: 47-48 p. digitalISSN:- 1576-6578
- Adrenal Cortex Hormones -- adverse effects
- Aged, 80 and over
- Autoantibodies -- blood
- Autoantigens -- immunology
- Denosumab -- therapeutic use
- Female
- Fractures, Spontaneous -- chemically induced
- Humans
- Myasthenia Gravis -- complications
- Osteoporosis -- chemically induced
- Pyridostigmine Bromide -- therapeutic use
- RANK Ligand -- antagonists & inhibitors
- Receptors, Cholinergic -- immunology
- Remission Induction
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.